{"id":"W2584416641","doi":"10.1182/blood.v120.21.lba-1.lba-1","title":"Two Doses of Apixaban for the Extended Treatment of Venous Thromboembolism","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Apixaban; Medicine; Placebo; Stroke (engine); Randomized controlled trial; Regimen; Internal medicine; Surgery; Myocardial infarction; Anticoagulant; Warfarin; Atrial fibrillation; Rivaroxaban","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001405207,0.0005065017,0.001553671,0.0003564802,0.0001999061,0.0005161362,0.0004571436,0.0008326073,0.008681886],"category_scores_gemma":[0.001968604,0.0002457872,0.001233461,0.0002339359,0.0003692531,0.0005497327,0.0002425973,0.001776273,0.0006614657],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000279586,"about_ca_system_score_gemma":0.0003990314,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001984998,"about_ca_topic_score_gemma":0.0001908534,"domain_scores_codex":[0.9991366,0.0004251012,0.0001310585,0.0001118109,0.0001458712,0.00004953193],"domain_scores_gemma":[0.9990496,0.0003045222,0.000343893,0.00005437356,0.00006985712,0.0001776879],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8371545,0.01050042,0.003749585,0.002751545,0.003173648,0.0001434494,0.00006485631,0.0006111313,0.01431187,0.0003847186,0.002713274,0.1244411],"study_design_scores_gemma":[0.7553399,0.2103935,0.02104698,0.0003125608,0.001718856,0.000441578,0.00003838982,0.001160324,0.003845401,0.0003254557,0.00534365,0.00003341593],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9611772,0.02998184,0.001654708,0.001022275,0.0009098363,0.001527717,0.0008222297,0.0001089165,0.002795266],"genre_scores_gemma":[0.9911588,0.004280301,0.0008650494,0.0005492192,0.0005150472,0.0007945066,0.0004426565,0.000007490835,0.001386864],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008681886,"threshold_uncertainty_score":0.02904385,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0325648414204759,"score_gpt":0.3138172204741338,"score_spread":0.2812523790536579,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}